These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
740 related items for PubMed ID: 18545147
1. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma. de Feraudy S, Mar N, McCalmont TH. Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147 [Abstract] [Full Text] [Related]
2. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases. Buonaccorsi JN, Plaza JA. Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901 [Abstract] [Full Text] [Related]
4. Procollagen 1 and Melan-A expression in desmoplastic melanomas. Leinweber B, Hofmann-Wellenhof R, Kaddu S, McCalmont TH. Am J Dermatopathol; 2009 Apr; 31(2):173-6. PubMed ID: 19318805 [Abstract] [Full Text] [Related]
5. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma. Gleason BC, Calder KB, Cibull TL, Thomas AB, Billings SD, Morgan MB, Hiatt KM, Smoller BR. J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522 [Abstract] [Full Text] [Related]
6. The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma. Wieland CN, Dyck R, Weenig RH, Comfere NI. J Cutan Pathol; 2011 Nov; 38(11):884-8. PubMed ID: 21883368 [Abstract] [Full Text] [Related]
7. Immunohistochemical distinction of cutaneous spindle cell carcinoma. Morgan MB, Purohit C, Anglin TR. Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422 [Abstract] [Full Text] [Related]
8. Spindle cell neoplasm of skin: diagnostic dilemma. Jain M, Singh S, Agarwal K. Indian J Pathol Microbiol; 2007 Oct; 50(4):814-6. PubMed ID: 18306566 [Abstract] [Full Text] [Related]
9. CD10-positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma. Clarke LE, Frauenhoffer E, Fox E, Neves R, Bruggeman RD, Helm KF. J Cutan Pathol; 2010 Jul; 37(7):737-43. PubMed ID: 20175824 [Abstract] [Full Text] [Related]
10. Procollagen 1 expression in atypical fibroxanthoma and other tumors. Jensen K, Wilkinson B, Wines N, Kossard S. J Cutan Pathol; 2004 Jan; 31(1):57-61. PubMed ID: 14675286 [Abstract] [Full Text] [Related]
11. CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. Monteagudo C, Calduch L, Navarro S, Joan-Figueroa A, Llombart-Bosch A. Am J Clin Pathol; 2002 Jan; 117(1):126-31. PubMed ID: 11789717 [Abstract] [Full Text] [Related]
12. Atypical fibroxanthoma with keloidal collagen. Fussell JN, Cooke ER, Florentino F, Sheehan DJ. Am J Dermatopathol; 2010 Oct; 32(7):713-5. PubMed ID: 20700041 [Abstract] [Full Text] [Related]
16. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome. Hanlon A, Stasko T, Christiansen D, Cyrus N, Galan A. Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637 [Abstract] [Full Text] [Related]